anosmin 1
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The ANOS1 gene, also known as KAL1, provides instructions for making a protein called anosmin-1. This protein is involved in development before birth. Anosmin-1 is found in the extracellular matrix, which is the intricate lattice of proteins and other molecules that forms in the spaces between cells. Anosmin-1 is active in many parts of the developing embryo, including the respiratory tract, kidneys, digestive system, and certain regions of the brain.
Video picks for GenesVideo library
Normal function
The ANOS1 gene, also known as KAL1, provides instructions for making a protein called anosmin-1. This protein is involved in development before birth. Anosmin-1 is found in the extracellular matrix, which is the intricate lattice of proteins and other molecules that forms in the spaces between cells. Anosmin-1 is active in many parts of the developing embryo, including the respiratory tract, kidneys, digestive system, and certain regions of the brain.
Researchers are working to determine the functions of anosmin-1. They have discovered that, in the developing brain, this protein is involved in the movement (migration) of nerve cells and the outgrowth of axons, which are specialized extensions of nerve cells that transmit nerve impulses. The protein also plays a role in regulating contact between nerve cells (cell adhesion).
Anosmin-1 appears to help control the growth and migration of a group of nerve cells that are specialized to process the sense of smell (olfactory neurons). These nerve cells originate in the developing nose and then migrate together to a structure in the front of the brain called the olfactory bulb, which is critical for the perception of odors. Studies suggest that anosmin-1 is also involved in the migration of neurons that produce a hormone called gonadotropin-releasing hormone (GnRH). Like olfactory neurons, GnRH-producing neurons migrate from the developing nose to the front of the brain. GnRH controls the production of several hormones that direct sexual development before birth and during puberty. These hormones are important for the normal function of the ovaries in women and testes in men.
Conditions referring to this gene or chromosome
Other names
adhesion molecule-like X-linked
ADMLX
anosmin-1
HHA
KAL
KAL1
KALIG-1
Kallmann syndrome 1 protein
Kallmann syndrome protein
KALM_HUMAN
KMS
WFDC19
Patient picks for Genes

Anorexia Q&A
How long does anorexia last?
Dr Sarah Jarvis Anorexia is most common among teenage girls, but it can develop much later in life. Bulimia affects about 1 in 12 women in the UK, usually from their late teens-40s. Both are much more common in women than in men, but men can be affected too. Until recently, there has been a particular stigma around eating disorders in people from ethnic minorities, but it is becoming clear that anyone can be affected, regardless of age, gender or ethnicity. [https://patient.info/health/eating-disorders/types-of-eating-disorder](https://patient.info/health/eating-disorders/types-of-eating-disorder)
by Dr Sarah Jarvis

Asthma & COPD
How do I know if I have asthma?
Dr Sarah Jarvis MBE The common symptoms are cough and wheeze. You may also become breathless and develop a feeling of chest tightness. Symptoms can range from mild to severe between different people and at different times in the same person. Each episode of symptoms may last just an hour or so, or persist for days or weeks unless treated. [https://patient.info/health/asthma-leaflet#nav-1](https://patient.info/health/asthma-leaflet#nav-1)
by Dr Sarah Jarvis

Risks of diabetes
How can I avoid getting a hypo?
Dr Sarah Jarvis MBE Hypoglycaemia, or low blood sugar, is often known as a 'hypo'. It can make you feel unwell and affect your ability to drive. Simple steps will reduce the risk, and allow you to treat a hypo early, before it causes more serious complications. For more information, go to [https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous](https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous)
by Dr Sarah Jarvis

Other diabetes
What does insulin do?
Dr Partha Kar In type 1 diabetes, the body stops making insulin and the blood sugar level goes very high. Some people who have type 2 diabetes may also need to have insulin injections to help control blood sugar levels. Insulin is usually injected under the skin between 2-4 times a day. For more information on insulin, go to [https://patient.info/health/type-1-diabetes/insulins](https://patient.info/health/type-1-diabetes/insulins)
by Dr Partha Kar, FRCP

Type 1 diabetes
How does type 1 diabetes affect your weight?
Dr Partha Kar The symptoms that usually occur when you first develop type 1 diabetes are: thirst, regular passing of urine, tiredness, weight loss and feeling generally unwell. For more information on type 1 diabetes, go to [https://patient.info/health/type-1-diabetes](https://patient.info/health/type-1-diabetes)
by Dr Partha Kar, FRCP

Diabetes Q&A
What should my blood sugar level be? | Patient
Hypoglycaemia, or low blood sugar, is often known as a 'hypo'. It can make you feel unwell and affect your ability to drive. Simple steps will reduce the risk, and allow you to treat a hypo early, before it causes more serious complications. Find out more: [https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous](https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous) Follow Patient: Website: [https://patient.info/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest: [https://uk.pinterest.com/patient/](https://uk.pinterest.com/patient/) Instagram: [https://www.instagram.com/patient.info/](https://www.instagram.com/patient.info/)
by Dr Partha Kar, FRCP
Related patient information and medicines

Patient information leaflet
Type 2 diabetes treatment
As soon as you. ...flet that comes in the medicine packet for full details of cautions and possible side-effectsGLP-1 (glucagon-like peptide-1) mimetics - exenatide, dulaglutide, liraglutide, lixisenatide and semaglutide Exenatide Exenatide for diabetes , dulaglutide, lixisenatide Lixisenatide for diabetes , liraglutide Liraglutide for diabetes ,.

Patient information leaflet
Immunisation for flu
Influenza (flu) Flu is a common viral infection that tends to be most common in the winter. Flu can cause much more severe symptoms than the common cold Common cold. Some people can become seriously ill with flu, needing hospital treatment, and it can be life-threatening. Certain groups of people, such as older adults and young children, are at.

Patient information leaflet
Bupropion for quitting smoking
If you want to stop smoking, taking bupropion (trade name Zyban®) roughly doubles your chance of success. What is bupropion. Bupropion (Zyban®) Bupropion tablets for help stopping smoking is a medicine that was first developed to treat depression. It was found that it helped smokers to stop smoking. It seems to relieve the withdrawal symptoms that.

Patient information leaflet
Wilson's disease
Wilson's disease is a genetic disorder in which copper builds up in the body, mainly in the liver and brain. Without any treatment, the build-up of copper can cause serious symptoms. Treatment is with medication to remove the excess copper and/or to prevent a further build-up of copper. What is Wilson's disease. Wilson's disease is a condition.

Patient information leaflet
Can I take Atorvastatin and Fibre supplements together?
Taking fibre supplements at the same time as atorvastatin can lower the amount of medicine your body absorbs. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Disclaimer This information is for general educational purposes only and should not be.

Patient information leaflet
Haemochromatosis
If treatment is started early enough and before complications occur then the outlook for people with haemochromatosis is very good. Find out more here: [https://patient.info/health/haemochromatosis-leaflet](https://patient.info/health/haemochromatosis-leaflet) People with haemochromatosis have inherited a faulty gene, which directs the body to.
Further reading and references
- anosmin 1; MedlinePlus, National Library of Medicine.
- Balasubramanian R, Crowley WF Jr. Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency. 2007 May 23 [updated 2022 May 12]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1334/
- Cariboni A, Pimpinelli F, Colamarino S, Zaninetti R, Piccolella M, Rumio C, Piva F, Rugarli EI, Maggi R. The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet. 2004 Nov 15;13(22):2781-91. doi: 10.1093/hmg/ddh309. Epub 2004 Oct 7.
- Choy C, Kim SH. Biological actions and interactions of anosmin-1. Front Horm Res. 2010;39:78-93. doi: 10.1159/000312695. Epub 2010 Apr 8.
- de Castro F, Esteban PF, Bribian A, Murcia-Belmonte V, Garcia-Gonzalez D, Clemente D. The adhesion molecule anosmin-1 in neurology: Kallmann syndrome and beyond. Adv Neurobiol. 2014;8:273-92. doi: 10.1007/978-1-4614-8090-7_12.
- Hardelin JP, Julliard AK, Moniot B, Soussi-Yanicostas N, Verney C, Schwanzel-Fukuda M, Ayer-Le Lievre C, Petit C. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev Dyn. 1999 May;215(1):26-44. doi: 10.1002/(SICI)1097-0177(199905)215:13.0.CO;2-D.
- Hardelin JP, Levilliers J, del Castillo I, Cohen-Salmon M, Legouis R, Blanchard S, Compain S, Bouloux P, Kirk J, Moraine C, et al. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8190-4. doi: 10.1073/pnas.89.17.8190.
- Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, Millasseau P, Le Paslier D, Cohen D, Caterina D, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell. 1991 Oct 18;67(2):423-35. doi: 10.1016/0092-8674(91)90193-3.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

